Drug Discovery · Neurology & CNS Therapeutics
Noema Pharma: Products & infrastructure
Noema Pharma has 6 clinical trials on record, 2 under way.
Data updated Nov 20, 2026 · Back to the company report
Products
Noema Pharma has 6 clinical trials on record, 2 under way.
6clinical trials
2trials under way
1in phase 3
Clinical trialsthe studies it sponsors or works on, per ClinicalTrials.gov
Efficacy and Safety of Gemlapodect (NOE-105) in Adults and Adolescents With Tourette Syndrome
phase 2 · under way · 164 participants · Tourette Syndrome
Sep 2024
A Study of NOE-115 in Women With Vasomotor Symptoms Due to Menopause
phase 2 · completed · 40 participants · Menopause Syndrome; Menopause; Hot Flashes
Apr 2024
A 10-week Efficacy Study of NOE-105 in Childhood Onset Fluency Disorder (Orpheus)
phase 2 · completed · 75 participants · Childhood-Onset Fluency Disorder
Jul 2022
Basimglurant (NOE-101) in Children, Adolescents, and Young Adults With TSC
phase 2 · completed · 61 participants · Tuberous Sclerosis Complex
Mar 2022
An Efficacy and Safety Study of Basimglurant (NOE-101) in Patients With Trigeminal Neuralgia.
phase 3 · under way · 166 participants · Trigeminal Neuralgia
Jan 2022
A Study to Validate a Pain Diary for Patient With Trigeminal Neuralgia
completed · 30 participants · Trigeminal Neuralgia
Nov 2021
Source: each app’s App Store and Google Play page (an app counts as the company’s when its developer site is on the company’s domain); the products its own site names.
